The STAT3 transcription factor is a target for the Myc and riboblastoma proteins on the Cdc25A promoter

Benjamin Barré1, Arnaud Vigneron, Olivier Coqueret

  • 1INSERM U564, Cancer Center Paul Papin, 49033 Angers, France.

Insights

Signal transducer and activator of transcription 3 (STAT3) and Myc cooperate to activate Cdc25A gene expression. The retinoblastoma (Rb) tumor suppressor regulates this STAT3 transcriptional activity.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Gene Regulation

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is crucial for cell growth and survival.
  • Constitutive STAT3 activation is linked to cancer development.
  • The precise mechanisms of STAT3's role in cell transformation are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which STAT3 regulates target genes involved in cell growth and transformation.
  • To investigate the role of STAT3 in the transcriptional activation of the Cdc25A gene.
  • To identify STAT3's cofactors and regulatory partners in gene expression.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) assays to detect protein binding to the Cdc25A promoter.
  • Small interfering RNA (siRNA) to knock down Myc expression.
  • Coimmunoprecipitation assays to study protein-protein interactions.
  • Western blotting to assess protein levels.

Main Results:

  • STAT3 and Myc are recruited to the Cdc25A promoter, activating its transcription.
  • Myc is essential for STAT3-mediated Cdc25A activation, facilitating the recruitment of Cdk9 and RNA polymerase.
  • STAT3 can also act as a transcriptional repressor of Cdc25A, forming a complex with the retinoblastoma (Rb) protein.
  • Rb directly binds to STAT3 and inhibits Cdc25A induction upon hydrogen peroxide stimulation.

Conclusions:

  • Myc and STAT3 collaborate to induce Cdc25A gene expression.
  • The retinoblastoma (Rb) tumor suppressor negatively regulates STAT3's transcriptional activity on the Cdc25A gene.
  • This study reveals a novel regulatory mechanism for STAT3-mediated gene expression involving both activation and repression by Rb.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...